| scholarly article | Q13442814 |
| P50 | author | Markus Wahrmann | Q38545557 |
| P2093 | author name string | F Mühlbacher | |
| G Fischer | |||
| W Druml | |||
| G A Böhmig | |||
| H Regele | |||
| G Bartel | |||
| Z Kikić | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2033-2042 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation | |
| P478 | volume | 10 |
| Q51762531 | ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial. |
| Q38544529 | Advances in pharmacotherapy to treat kidney transplant rejection |
| Q37698860 | Antibody-Mediated Rejection: A Review |
| Q38082735 | Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease |
| Q35922715 | Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection |
| Q38002449 | Cardiac antibody-mediated rejection |
| Q37446864 | Challenges with sensitized recipients in pediatric heart transplantation. |
| Q38609238 | Complement inhibition as potential new therapy for antibody-mediated rejection. |
| Q37836967 | Current approaches to the management of highly sensitized kidney transplant patients |
| Q38096463 | Current pharmacotherapeutical options for the prevention of kidney transplant rejection |
| Q40749159 | Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection. |
| Q38195324 | Desensitization in kidney transplantation: review and future perspectives |
| Q26998713 | Detection and clinical relevance of donor specific HLA antibodies: a matter of debate |
| Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
| Q38144106 | Impact of donor-specific antibodies in reconstructive transplantation |
| Q37660263 | Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy |
| Q40183610 | Increased risk of infection-associated death with incompatible kidney transplantations. |
| Q51579669 | Kidney transplantation for high-risk sensitized patients - the "Heidelberg algorithm". |
| Q37854488 | Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch? |
| Q51413561 | Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. |
| Q38840335 | Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants |
| Q38010231 | Prevention of antibody-mediated kidney transplant rejection |
| Q40956620 | Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy. |
| Q47779198 | Protein a Immunoadsorption May Hamper the Decision to Transplant Due to Interference With CDC Crossmatch Results. |
| Q59356949 | Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients |
| Q38030174 | Recent developments in desensitization of crossmatch-positive kidney transplant recipients |
| Q35022239 | Strategies to increase the donor pool and access to kidney transplantation: an international perspective |
| Q38048605 | The role of complement in antibody-mediated rejection in kidney transplantation |
| Q30458220 | Therapeutic apheresis in renal transplantation; current practices |
| Q38831291 | Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation. |
| Q89605533 | Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial |
Search more.